FAQ

FAQ

FAQ

The Accure Acne Laser System is a revolutionary device FDA-cleared for the treatment of mild to severe inflammatory acne vulgaris on the face and body.

It is a non-systemic, non-invasive, fast, safe, and reliable acne solution that uses a precise 1726 nm wavelength laser to selectively target overactive sebaceous glands and reduce sebum production in all skin types.1

The full treatment consists of a series of four treatment sessions, each completed one month apart.2

Prior to treatment the area being treated is numbed with an injectable or topical numbing agent. A majority of patients find the treatment tolerable, with minimal discomfort reported afterwards.3

Most patients experience little to no downtime after treatment. The skin might be flushed, red, or puffy after treatment, but this resolves within a few days. Most people resume regular activities without disruption. Some people may experience a temporary acne flare-up, which is normal.

While other energy devices use a limited “treat-to-power” approach, the Accure Acne Laser System uses a sophisticated thermal imaging camera to constantly assess the skin’s temperature, in combination with a powerful cooling system. This “treat-to-temperature” approach, coupled with optimized depth penetration, allows for more precise targeting of the sebaceous glands while preserving surrounding tissues. 

Patients can expect visible results after the first treatment,4 with 70% average acne reduction at 6 months after the full series of four treatments.5 Studies show some patients maintained significant results almost 3 years after their series of Accure treatments!3

References:
  1. In multiple IRB-approved trials, patients of all Fitzpatrick skin types were included and treated, with no differences in target temperature or outcomes. Data on file, Accure Acne, Inc. Individual results may vary.

  2. Dermatologist will determine a treatment plan based on each patient’s need. Individual results may vary.

  3. Data on file, Accure Acne, Inc. Individual results may vary.

  4. In multiple IRB-approved studies, patients showed an average 29% reduction after the first treatment. Data on file, Accure Acne, Inc. Individual results may vary.

  5. In IRB-approved studies, patients showed an average 70% reduction in acne lesions 6 months after 4 treatments, spaced 1 month apart. Data on file, Accure Acne, Inc. Individual results may vary.